Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Bloom Energy
BE
$59.3B
| $74.5M | 0.09% |
246,157
+122,640
| +99% | +$31.4M |
|
252
Gilead Sciences
GILD
$181B
| $74.2M | 0.09% |
587,082
+567,308
| +2,869% | +$74.7M |
|
253
CALL
State Street Energy Select Sector SPDR ETF
XLE
$41.7B
| $73.9M | 0.09% |
1,391,400
-1,004,600
| -42% | -$57.4M |
|
254
Polaris
PII
$3.66B
| $73.9M | 0.09% |
+1,079,296
| New | +$69.5M |
|
255
PUT
Uber
UBER
$161B
| $73.6M | 0.09% |
1,020,400
+299,400
| +42% | +$22M |
|
256
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$45.5B
| $73.6M | 0.09% |
463,700
+3,700
| +0.8% | +$550K |
|
257
PUT
UnitedHealth
UNH
$350B
| $73.5M | 0.09% |
176,800
+21,700
| +14% | +$8.04M |
|
258
Unifirst Corp
UNF
$5.25B
| $73.4M | 0.09% |
277,520
-57,853
| -17% | -$15.1M |
|
259
Global E Online
GLBE
$6.81B
| $72.9M | 0.09% |
2,098,803
-116,323
| -5% | -$3.68M |
|
260
PUT
IonQ
IONQ
$18.2B
| $72.8M | 0.09% |
1,367,000
+1,217,000
| +811% | +$61.7M |
|
261
Synopsys
SNPS
$76.2B
| $72.7M | 0.09% |
162,940
+151,052
| +1,271% | +$71M |
|
262
PUT
Rivian
RIVN
$24.6B
| $72.6M | 0.09% |
4,184,500
-1,628,400
| -28% | -$25.4M |
|
263
Best Buy
BBY
$18.1B
| $72.6M | 0.09% |
956,230
+952,925
| +28,833% | +$63.3M |
|
264
Vertex Pharmaceuticals
VRTX
$139B
| $72M | 0.09% |
145,005
+104,868
| +261% | +$46.5M |
|
265
Oracle
ORCL
$422B
| $71.3M | 0.09% |
486,649
+165,559
| +52% | +$30M |
|
266
Cooper Companies
COO
$14.9B
| $71M | 0.09% |
990,419
+752,801
| +317% | +$49.2M |
|
267
Mettler-Toledo International
MTD
$28B
| $69.9M | 0.09% |
54,686
+6,738
| +14% | +$8.12M |
|
268
Shopify
SHOP
$192B
| $69.5M | 0.09% |
+609,006
| New | +$69.5M |
|
269
PUT
ExxonMobil
XOM
$679B
| $69M | 0.09% |
504,800
-247,500
| -33% | -$37M |
|
270
BJs Wholesale Club
BJ
$12.3B
| $69M | 0.09% |
+790,616
| New | +$72.4M |
|
271
Macy's
M
$6B
| $68.9M | 0.09% |
+2,926,748
| New | +$61.3M |
|
272
Valero Energy
VLO
$100B
| $68.9M | 0.09% |
264,524
+16,858
| +7% | +$4.15M |
|
273
Colgate-Palmolive
CL
$72.6B
| $68.7M | 0.09% |
749,667
+730,960
| +3,907% | +$64M |
|
274
Glaukos
GKOS
$10.9B
| $68.7M | 0.09% |
+491,636
| New | +$62.2M |
|
275
Abbott
ABT
$202B
| $67.2M | 0.08% |
740,808
-103,643
| -12% | -$9.46M |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.